Literature DB >> 11561105

Medical therapy for rheumatoid arthritis--value for money?

C M Lambert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11561105     DOI： 10.1093/rheumatology/40.9.961

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Cost-minimisation analysis of subcutaneous methotrexate versus biologic therapy for the treatment of patients with rheumatoid arthritis who have had an insufficient response or intolerance to oral methotrexate.

Authors:  Ray Fitzpatrick; David Gi Scott; Ian Keary
Journal:  Clin Rheumatol       Date:  2013-07-09       Impact factor: 2.980

Review 2.  Health economics: implications for novel antirheumatic therapies.

Authors:  A Kavanaugh
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

3.  Annual costs of rheumatoid arthritis in Turkey.

Authors:  Simten Malhan; Lale Aktekin Akbulut; Hatice Bodur; Cankat F Tulunay
Journal:  Rheumatol Int       Date:  2009-07-07       Impact factor: 2.631
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.